Bertelsmann Investments

Ataraxis is an AI-based diagnostic platform that helps develop personalized treatment plans.

Guardoc Health is streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.

deepc GmbH, based in Munich, Germany, specializes in developing AI software for medical imaging, particularly in radiology, to minimize diagnostic errors. The company offers a disease-agnostic AI solution that analyzes medical imaging data in real-time, identifying healthy and non-healthy cases to enhance diagnostic accuracy. Its web-based AI software framework, referred to as the Diagnostics OS, facilitates the integration of various medical diagnostic AI tools into clinical workflows, improving efficiency and cost-effectiveness. By serving as a central hub for artificial intelligence applications in radiology, deepc aims to support healthcare professionals in achieving faster, more accurate diagnoses, ultimately leading to better patient outcomes. The company has received recognition for its innovative contributions, including awards from the Federal Ministry for Economic Affairs and Energy.

Phare Health transforms the back office of healthcare, making it more efficient, accurate, and resillient.

QuantHealth develops artificial intelligence-based software aimed at enhancing drug development processes. The company's platform conducts patient-centric simulations that integrate various data points from the clinical and drug development landscape. By predicting patient responses to both existing and new therapies, QuantHealth enables pharmaceutical and biotechnology companies to test different clinical trial designs. This capability helps optimize trial strategies, ultimately increasing the chances of successful outcomes. Through its innovative approach, QuantHealth supports the healthcare industry in identifying new clinical opportunities and refining development strategies.

Onqo Health - Intelligent support for individual and guideline-compliant therapy recommendations Onqo Health was founded in 2013 by physicians from the University Hospital Cologne. Today, a team of over 40 oncologists, scientists, and developers, together with an extensive network, are working to improve the quality of cancer care by translating the latest research into therapy algorithms. The precise, guideline-compliant therapy recommendations (including Best Clinical Practice) are qualitatively assured and individually support the decision on the optimal therapy for each individual patient. This allows, based on the evidence obtained, to measure oncological care and to return real treatment data to research. At Onqo, we believe that by combining science and technology, we can significantly reduce misdiagnosis rates - by providing the relevant information to the right people at the right time. EasyOncology is a Decision Support System for solid tumors and, with approximately 6,000 downloads, it's now the leading app for oncology professionals. This certified medical product presents the standards for diagnostics, therapy planning, and follow-up care in a very clear and concise manner, making it intuitive, quick, and goal-oriented. Users are guided from question to answer in less than five clicks. Unlike other mediums, the stage-appropriate therapy recommendation is first given in a brief overview to quickly grasp the therapeutic principle. Depending on the information needed, this can be explored in more detail. The oncological action recommendations are continuously retrospectively matched with decisions from tumor boards and thus validated. This is collected as part of a scientific accompanying program. From this, the idea developed to offer this system as an interface (API) for tumor board software, in order to reduce the high number of cases discussed in the tumor boards. This way, they can be quantitatively relieved and have more time available for complex cases. After entering all relevant information into the tumor board request, Board Support immediately generates a therapy recommendation. Standard cases with therapy recommendations no longer need to be presented at the board or can be consented in advance. Significant insights regarding the efficiency of therapies, the quality of treatments, etc., are obtained from the accompanying usage data. Board Support is currently in the pilot phase. onqo is a digital companion for NSCLC patients, supporting them on their journey with individualized, evidence-based, and comprehensible information for optimal oncological care. An interactive query allows for the personalized provision of information on the treatment course, including event-related notifications. This empowers patients to better understand their own illness, comprehend why certain therapeutic decisions are made, and recognize, based on the latest medical findings, the optimal treatment for their individual situation. onqo promotes guideline-compliant treatment by determining the right next steps based on previous user responses and highlighting deviations from these. onqo provides a summary of the collected information to present at the next doctor's appointment. To always have all important information in one place, findings or doctor's letters can be saved in the app, as well as questions and notes. Additionally, onqo offers valuable knowledge about cancer, covering all relevant medical topics, but also accompanying subjects like exercise, financial security, or dealing with stress. Additionally, onqo provides valuable knowledge about cancer, covering all relevant medical topics, as well as accompanying subjects like exercise, financial security, or stress management. In aftercare, onqo regularly asks about important general symptoms that can be summarized in the next treatmentdiscussion as soon as a significant change is detected.

Patient21 operates a health platform focused on improving the doctor-patient connection, which they view as essential for effective healthcare. The company aims to modernize the healthcare experience by addressing the fragmented and outdated processes currently prevalent in the industry. By leveraging technology, Patient21 enhances dental clinics with management software that streamlines administrative tasks such as appointment scheduling and patient data management. They also provide electronic health records (EHR) to healthcare professionals, which helps improve diagnostic quality and reduce costs. Through these innovations, Patient21 seeks to facilitate better decision-making for both patients and physicians, ultimately promoting a more personalized and collaborative approach to healthcare.

deepc GmbH, based in Munich, Germany, specializes in developing AI software for medical imaging, particularly in radiology, to minimize diagnostic errors. The company offers a disease-agnostic AI solution that analyzes medical imaging data in real-time, identifying healthy and non-healthy cases to enhance diagnostic accuracy. Its web-based AI software framework, referred to as the Diagnostics OS, facilitates the integration of various medical diagnostic AI tools into clinical workflows, improving efficiency and cost-effectiveness. By serving as a central hub for artificial intelligence applications in radiology, deepc aims to support healthcare professionals in achieving faster, more accurate diagnoses, ultimately leading to better patient outcomes. The company has received recognition for its innovative contributions, including awards from the Federal Ministry for Economic Affairs and Energy.

PAICON is a pioneering healthcare technology company dedicated to revolutionizing the medical field through its uniquely diverse and comprehensive medical data lake. Thier platform integrates genetically and technically diverse data, enabling innovative solutions in diagnostics, personalized medicine, and AI-powered healthcare applications. PAICON’s mission is to eliminate biases in healthcare algorithms, ensuring accurate and equitable treatment for all patients. By collaborating with pharmaceutical companies, research institutions, and healthcare providers, PAICON is at the forefront of driving advancements in precision medicine and improving patient outcomes worldwide.

Qunomedical is a digital health platform that is providing patients worldwide access to high-quality affordable healthcare. They believe that the ultimate healthcare choice of—what to do, where to go, and with whom to have a procedure, is made easier with someone you trust on your side. Qunomedical strives to be that someone for you. Their goal is to be your partner through your healthcare experience, and to open the doors to the highest quality information, doctors, clinics and care—worldwide. All too often, their health systems follow a one-size-fits-all approach, leaving patients to fend for themselves with too little treatment information, long waiting times, and no individualized care support. Qunomedical is here to change that. No two patients are alike—from their medical needs, to their emotional demands and comfort levels, everyone has different priorities and requests when it comes to handling their healthcare.

SubjectWell operates a clinical trials marketplace focused on patient recruitment. The company provides a platform that facilitates the recruitment and screening of patients for clinical trials, allowing healthcare organizations to secure highly qualified referrals. By streamlining the patient recruitment process, SubjectWell enables clients to expedite their studies and enhance the efficiency of clinical trials. The marketplace is designed to be risk-free, ensuring that both healthcare providers and patients can engage in the trial process with confidence.

Naluri Hidup Sdn Bhd, founded in 2017 and based in Kuala Lumpur, Malaysia, provides professional coaching, guidance, and therapy focused on enhancing mental resilience and achieving personal life goals. The company offers both in-person counseling sessions with qualified psychologists and a digital therapeutics platform that integrates behavioral science, data science, and digital design. This platform aims to support users in adopting healthier lifestyles, managing stress, and addressing cardiometabolic and mental health conditions. By combining these elements, Naluri helps individuals and organizations predict, prevent, and manage health challenges, ultimately promoting sustained health outcomes.

AppLike is a Hamburg-based company founded in 2015 that specializes in developing applications for mobile devices. It offers a range of services including mobile advertising, app recommendations, and B2B solutions tailored for the mobile apps market. The company focuses on creating and publishing engaging mobile games, emphasizing user-friendly monetization strategies. Additionally, AppLike provides software solutions that automate user acquisition processes, helping clients effectively distribute advertisements across various mobile platforms. By covering the full value chain of the mobile app ecosystem, AppLike aims to enhance the overall experience for both developers and users.

Speedoc is a virtual clinic and healthcare platform that aims to provide hospital-level care directly to patients' homes, addressing the increasing demand for medical services due to aging populations. The company offers a range of services including house call doctors, nurses, medication delivery, and telemedicine, which is supported by remote diagnostics and health monitoring. Through its application, users can easily book non-emergency private ambulances or request on-demand medical consultations, ensuring access to licensed healthcare professionals at any time and from any location. By integrating physical and digital healthcare services, Speedoc seeks to challenge traditional, facility-based medical models.

Knockri is an AI video skills assessment tool that uses a similar way to measure employers. The company helps reduce unconscious bias and shortlists the best-fit job candidates to interview, during the early screening process of hiring. It also helps eliminate unsuccessful interviews, by merging video intelligence, artificial intelligence, and science to quantify soft skills like confidence and empathy. Knockri's algorithm is blind and has been trained not to account for skin color, race, ethnicity, gender, appearance, or sexual preference as measures of desirability for a hire. The company's video and written screening platforms can seamlessly integrate into the existing Applicant Tracking System, that can easily plug-in their ready to go algorithm (API) into the existing interview and conference platforms.